Skip to main content
OpenTrials

Clinical trial condition

Intestinal Neoplasms

Explore clinical trials studying Intestinal Neoplasms. Study availability and eligibility vary by location and protocol.

6,344 public trials 1,368 recruiting studies
Refine in advanced search Browse all conditions

Intestinal Neoplasms trial results

Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

NCT07213609

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +22 more
Locations
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site Detroit, Michigan, United States
  • GSK Investigational Site Canton, Ohio, United States
  • GSK Investigational Site Nashville, Tennessee, United States
View all 22 locations
View Trial Details
Recruiting

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

NCT07114601

Conditions
Breast Diseases, Breast Neoplasms, Colonic Diseases, +37 more
Locations
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
View all 31 locations
View Trial Details
Recruiting

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

NCT04929223

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • cCare Encinitas, California, United States
View all 84 locations
View Trial Details
Recruiting

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

NCT07186842

Conditions
Adnexal Diseases, Advanced Solid Cancers, Bile Duct Diseases, +29 more
Locations
  • SCRI at HCA Health One Denver, Colorado, United States
  • Florida Cancer Specialists Orlando, Florida, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Monash Health Clayton, Australia
View all 16 locations
View Trial Details
Recruiting

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

NCT05108298

Conditions
Bone Cancer, NOS, Bone Diseases, Bone Neoplasms, +67 more
Locations
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Kingman Regional Medical Center Kingman, Arizona, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
View all 347 locations
View Trial Details
Recruiting

COLON ERDERLY LOW DOSE

NCT06840977

Conditions
Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +9 more
Locations
  • E.O. Ospedali Galliera Genova, GE, Italy
  • E.O. Ospedali Galliera Genoa, Liguria, Italy
View Trial Details

Related conditions